Stocks

Rep. David Taylor Bets Big on Amgen Amid Biotech Company's Recent Slide

Guavy AI Editorial Team Published October 3, 2026

Instruments

AMGN

Representative David Taylor (Republican-Ohio) recently disclosed that he bought between $1,001 and $15,000 in Amgen Inc. (NASDAQ:AMGN) stock on September 22nd. The trade occurred in his 'DAVID TAYLOR TRUST > SARDINIA READY MIX 401(K) - DAVE' account.

Amgen's shares have taken a hit after the company dropped 10% following a trial it didn't even run. Despite this, Taylor still chose to invest in the biotechnology company.

The Wire

Keep reading for free.

You've read 3 free articles in the last 24 hours. Create a free account for unlimited access, no card required.

Create free account Already have an account? Sign in

No spam. Unsubscribe anytime.

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

Terms Privacy Policy